NIVF SEC Filings: 8-K, 10-Q, S-3 & 424B – NewGenIvf

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 31, 2026

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

May 15, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 22, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Aug 19, 2024

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Apr 30, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 9, 2024

News

TYPE

HEADLINE

FILED AT

6-K/A

Six-Month Revenue Slips 4.7% as Net Loss Widens to $8.0 Million Despite Gross Margin Improvement to 24.1%

Oct 27, 2026

6-K

Eight-for-one reverse stock split takes effect October 23, with split-adjusted Nasdaq trading and new CUSIP number

Oct 21, 2026

6-K

Newgen IVF Group Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

Oct 7, 2026

6-K

NewGenIvf Group Limited Announces 1-for-4 Reverse Stock Split

Oct 7, 2026

6-K

NewGenIVF Group Limited Reports Total Issued and Outstanding Class A Ordinary Shares of 27,287,002 as of October 1, 2026

Oct 5, 2026

6-K

NewGen Announces Pricing of $1.25 Million Public Offering

Sep 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Sep 30, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 100,000,000

Mar 13, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 50,000,000

Oct 31, 2025

424B3

SHARE RESALE REGISTRATION | Shares: 22,027,500

Jun 3, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 139,425,259 | Warrants amount: 22,885,950

Nov 8, 2024

424B3

UPDATED

Mar 1, 2024

Registrations

TYPE

HEADLINE

FILED AT

F-3/A

NEWNovember 2026 SHELF | Float: 1,550,309

Nov 9, 2026

F-3

October 2026 SHELF | Float: 1,188,914

Oct 27, 2026

DRS

Form DRS - Draft Registration Statement

Oct 9, 2026

F-1/A

OFFERING - Best Efforts EFFECTIVE, DATED 2026-09-28

Sep 10, 2026

F-1/A

SHARE RESALE REGISTRATION | Shares: 3,555,900 EFFECTIVE, DATED 2026-09-28

Sep 1, 2026

F-1

OFFERING (Best Efforts) - Aegis Capital Corp. EFFECTIVE, DATED 2026-09-28

Aug 20, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13D/A

Siu Wing Fung Alfred (Filed by)

Oct 6, 2026

Siu Wing Fung Alfred (Reporting)

Oct 6, 2026

Fong Hei Yue Tina (Reporting)

Oct 6, 2026

Lau Tsz Hin Vincent (Reporting)

Sep 4, 2026

Lam Chun Tung Patrick (Reporting)

Sep 2, 2026

Cheung Kong Yiu (Reporting)

Sep 2, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 29, 2026

CORRESP

Form CORRESP - Correspondence

Sep 24, 2026

CORRESP

Form CORRESP - Correspondence

Sep 24, 2026

CORRESP

Form CORRESP - Correspondence

Sep 1, 2026

LETTER

Form UPLOAD - SEC-generated letter

Aug 27, 2026

CORRESP

Form CORRESP - Correspondence

Aug 20, 2026

NewGenIvf Group Limited NIVF · SEC Filings